Início › Linfoma folicular › Nova York
Ensaios clínicos de Linfoma folicular em Nova York
30 estudos para Linfoma folicular estão buscando participantes em locais em Nova York.
Cidades em Nova York
- New York City24 estudos
- Queens7 estudos
- Greenburgh6 estudos
- Buffalo5 estudos
- Rochester4 estudos
- New Rochelle4 estudos
- Staten Island4 estudos
Texto oficial do estudo (Inglês)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Northwell Health Imbert Cancer Center, Bay Shore
- NYU Langone Hospital - Brooklyn, Brooklyn
- Memorial Sloan Kettering Commack, Commack
- e mais 9
RecrutandoFase 3
Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07215910A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, New York
- Research Site, New York
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Roswell Park Comprehensive Cancer Center, Buffalo
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- e mais 1
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05006716Epco, Zanu, Ritux for R/R FL or MZL
- Memorial Sloan Kettering Cancer Center, New York
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06563596A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Columbia University, New York
- University of Rochester, Rochester
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- New York University Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Albany
- Research Site, New Hyde Park
- Research Site, New York
- e mais 2
RecrutandoFase 3
Idades de 18 a 130 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06549595Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, New York
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Mount Sinai Medical Center, New York
RecrutandoFase 3
Idades de 12 a 100 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Icahn School of Medicine at Mt Sinai, New York
- Stony Brook University Hospital, Stony Brook
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06091254Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT05303519A Study of ARC-02 in B-cell NHL
- NYU Langone, New York
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Roswell Park Comprehensive Cancer Center, Buffalo
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT05826535rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
- New York State Psychiatric Institute (NYSPI) / Substance Treatment and Research Service (STARS), New York
Recrutando
Idades de 22 a 65 · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05974202A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Stony Brook University Hospital, Stony Brook
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06149286A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT05389293Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- New York Medical College, Valhalla
RecrutandoFase 1/2
Idades de 13 a 90 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06533579This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center - Bergen, New York
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 24 de jul. de 2026 · NCT07121946Chronic CED of TPT for Recurrent Malignant Glioma
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT06666712Epcoritamab and Rituximab for First-line Follicular Lymphoma
- Icahn School of Medicine at Mount Sinai Hospital, New York
- University of Rochester Medical Center, Rochester
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT05783609Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- New York Medical Center, Valhalla
RecrutandoFase 1/2
Idades de 12 a 70 · Todos os sexos · Atualizado em 15 de abr. de 2026 · NCT04491370Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
- Icahn School of Medicine at Mount Sinai, New York
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mar. de 2026 · NCT06510361A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de fev. de 2026 · NCT07029217Study of SGR-1505 in Mature B-Cell Neoplasms
- Roswell Park Comprehensive Cancer Center, Buffalo
- Weill Cornell, New York
- Montefiore Medical Center, The Bronx
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT05544019A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
- University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center), Rochester
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de jan. de 2026 · NCT04669171AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Optum Medical Care PC, Westbury
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 10 de dez. de 2025 · NCT05602363SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- e mais 2
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
- New York Medical College, Valhalla
RecrutandoFase 2
Idades de 3 a 31 · Todos os sexos · Atualizado em 8 de ago. de 2025 · NCT02393157Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.